So the way these guys end up in these positions (Head of

New Post Public Reply Private Reply Replies (0) Message Board
Katangolo USS JOHNSTON #146998
617
So the way these guys end up in these positions (Head of Clinical Development/R&D is that they were usually experts in their field in this case HIV or infectious diseases and they usually have a lot of experience running clinical trials. They work in big practices that usually are affiliated with hospital systems and they work their way up in those practices to being one of the go to people for a given disease state - An expert.

They are building their résumé and writing papers and running clinical trials and going to conferences. They are gaining the respect from other experts in the field, and the cream rises to the top. Pharmaceutical companies are well aware of who the top dogs are and meet with them on a regular basis for things like advisory board meetings or at conferences or other meetings.

All of the competing pharmaceutical companies in That given disease state know who these doctors are and they’re all competing for their time and opinions and many of them will try and bring them over as an advisor for the pharmaceutical company. Sometimes that then leads to a permanent position within the company where they might head research and development for a given disease state like HIV.

But they if perform well within the pharmaceutical company then They move up the chain and begin to understand the other disease states that that company might be looking at. So if they have cancer division, they might be working on projects with the cancer division. Same with drugs that work in nephrology or Neurology, etc.

They talk in the halls and they talk in meetings and they get to know one another’s disease states and the drugs that are important for it, and as they progress in their career, they move their way up to head other departments within the company, and eventually they may become the head of all clinical programs and research and development. Some will get an advance business degree like Dr. LA did which helps.

So just because he specialized in infectious diseases and HIV doesn’t mean he hasn’t had exposure to all of the other disease states in those companies he worked for. If you reach that level, you have a broad understanding of pharmaceuticals and a broad understanding of different disease states. To earn that title, he has Put in the work and shown he can do the job And we are now fortunate to have him “consulting” us.

Hope that helps

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LITE, RRC, SGRY: Are Shareholders Getting Shortchanged?

Updated Category News Views 51

What's Really Going On Here? Here's the skinny: Halper Sadeh LLC, that hard-hitting investor rights law firm, is poking their noses into some potential red flags over at a few companies you might have heard of—Lumentum Holdings (NASDAQ:LITE), Range Resources (NYSE:RRC), and Surgery Partners (NASDAQ:SGRY). They're sniffing around transactions that might leave the regular...

Continue Reading
Tokenized Securities: Transfer Online's Next Frontier

Updated Category News Views 91

Transfer Online Teams Up with OnchainTA Hold onto your investment hats, folks—Transfer Online is linking arms with OnchainTA to step right into the future playground of tokenized securities. Now, what's that mean? Well, it's like jumping from sailing schooners to speedboats; we're entering a whole new era in capital markets. What's At Stake? The pair-up between these...

Continue Reading
Cboe Fights CFTC Over Single-Stock Derivative Approval

Updated Category News Views 194

The Battle Begins: Cboe's Legal Action Cboe Global Markets, the big kahuna in the equities and index derivatives scene, ain't just rolling over quietly. They've hopped on board with the Capital Markets Alliance in a legal dust-up against the Commodity Futures Trading Commission's (CFTC) decision to allow perpetual derivatives on U.S. stocks and ETFs. We're talking major...

Continue Reading
First Industrial Declares Regular Dividend Amid Growth Insights

Updated Category News Views 116

Dividend Declaration Reflects Confidence First Industrial Realty Trust, folks, just put another office stamp on their ongoing reliability quest—and I'm talking dividends. They're shelling out a tidy $0.50 per share for Q4 2026, with stockholders due to see the cash on January 19, 2027. That's like clockwork precision, showing a steadiness in what some call the unruly...

Continue Reading
Healthcare Consulting Market Hits $56.99B by 2031

Updated Category News Views 0

Market Set to Boom: $56.99 Billion by 2031 Grab your coffee and take a seat—this isn't your usual healthcare spiel. The healthcare consulting services market's cruising down a rapid growth highway, projected to tap dance to a whopping $56.99 billion by 2031, starting from $35.55 billion last year. We're talking a solid 9.9% CAGR, folks. Now, anytime numbers stack this...

Continue Reading
Eunice Goldstein Winery's Luxe Holiday Gifting Revolution

Updated Category News Views 64

Shaking Up the Holiday Gifting Game You ever feel like holiday gifting is stuck in a rut? Same old generic bottles and baskets. But, here comes Eunice Chiweshe Goldstein Winery, charging in with a fresh take on holiday generosity. This ain't just about selling wine—this is about crafting an experience for both giver and receiver. Perfect for those looking to ditch the...

Continue Reading
Micropos Medical's Push in High-Precision Radiotherapy

Updated Category News Views 75

Micropos Medical's Bold Steps into Radiotherapy Let's put a spotlight on a niche that's crying for attention: Micropos Medical is making waves in how we treat prostate cancer. They're leveraging technology with their Raypilot System, and they're partnering with the big guns at Johns Hopkins Medicine. Think about it — five patients in the U.S. are already seeing how this...

Continue Reading
Satisfi Labs Secures Two AI Patents, Boosts Reach

Updated Category News Views 54

Paving the Future with Patents Ah, patents. Like stock dividends for the tech world—they don’t change everything outright but can signal some mighty good things ahead. This time around, it’s Satisfi Labs who are in the spotlight. They’ve bagged not one, but two shiny U.S. patents to bolster what they’re calling Satisfi Forward. Honestly, it sounds like a...

Continue Reading
Terakeet's Game-Changer Moves: Mac Cummings' Vision

Updated Category News Views 112

Mac Cummings: A Maverick at Terakeet's Helm So, here’s the deal—we’ve got Mac Cummings, a guy who's shaking up the marketing world just when we thought we had it all figured out. When you get a nod from ADWEEK's Innovator 50, it isn't because you played it safe. It's because you believed in disrupting the status quo. Cummings has taken Terakeet from a humble start...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 142

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading

Top 5 Most Recently Viewed Articles

Bluerock High Income Fund Delivers Impressive Returns in 2025

Updated Category News Views 137

Bluerock High Income Fund Announces Latest Financial Updates Bluerock High Income Institutional Credit Fund, a notable player in the investment landscape, has recently revealed its quarterly distribution figures. Currently, the Fund is set to distribute approximately $0.52 per share, which translates to a remarkable 9.0% annualized distribution rate. This latest...

Continue Reading
Airlink Inc. Welcomes New Board Members for Critical Mission

Updated Category News Views 194

Airlink Inc. Welcomes New Leadership for 2025-2027 Airlink, Inc. is excited to introduce its new Board of Trustees members for the upcoming term, bringing a wealth of experience across diverse fields crucial to the aviation sector. This year's board welcomes six new members whose backgrounds span law, engineering, technology, and international relations, perfect for...

Continue Reading
MindHYVE.ai™ Demonstrates ChironAI™ at Leading CME Event

Updated Category News Views 291

MindHYVE.ai™ Demonstrates ChironAI™ at Leading CME Event MindHYVE.ai™ recently made an impactful appearance at a prestigious Continuing Medical Education (CME) session focused on innovations in cardiovascular imaging. The event gathered a variety of healthcare professionals including senior cardiologists, radiologists, and imaging specialists from various regions,...

Continue Reading
Optimized Projections for McDonald's Stock Amid Growth Trends

Updated Category News Views 200

UBS Adjusts Price Target for McDonald's Stock McDonald's Corporation (NYSE: MCD) has recently captured the attention of investors, as UBS has raised its price target on the fast-food giant's stock from $305 to an impressive $345. This revision is buoyed by strong sales growth potential that the company is expected to experience through the end of 2024 and into 2025. With...

Continue Reading
Kroger-Albertsons Merger: Key Insights and Market Impact

Updated Category News Views 203

Understanding the Kroger-Albertsons Merger Situation The legal proceedings surrounding the merger between Kroger and Albertsons have the potential to reshape the grocery industry considerably. This courtroom battle is crucial, as it involves the largest supermarket merger proposal in U.S. history, raising numerous concerns from both consumers and investors. Initially...

Continue Reading